Title : Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.

Pub. Date : 2018 Jun 29

PMID : 29958542






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We aim to investigate the potential therapeutic effects of combined therapy of resveratrol and metformin on polycystic ovaries via SIRT1 and AMPK activation. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
2 Resveratrol and metformin increased SIRT1 and AMPK immunreactivity, respectively, compared to the PCOS group. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
3 CONCLUSIONS: The results suggest that combined therapy of metformin and resveratrol may improve the weight gain, hormone profile and ovarian follicular cell architecture by inducing antioxidant and antiinflammatory systems via SIRT1 and AMPK activation in PCOS. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus